. Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron. 2008 Nov 26;60(4):534-42. PubMed.


Please login to recommend the paper.


  1. Because all therapeutic trials based on the amyloid cascade are, up to now, failures, all other hypotheses are welcome. Especially if they able to generate new potential anti-Alzheimer drugs.

Make a Comment

To make a comment you must login or register.